A drug failed by unreliable measurement is recorded as a drug that did not work.
An Australian research and development company applying AI, backed by deep clinical and scientific expertise, to improve how outcomes are measured and trusted in clinical trials.
Every trial resolves to one number.
Everything upstream — the molecule, the sites, the participants, the years — resolves to whether one measured number separates from control. It is the most consequential measurement in the industry, and the least industrialised. The measurement breaks in five predictable places.
Where the measurement breaks →Six ways to make an endpoint trustworthy.
Clinical endpoint adjudication
All source data in one lake, AI stratification so committees only review genuine cases, and an auditable determination workflow.
Learn more →Endpoint quality surveillance
Anomaly detection across every rating in the trial, plus an independent central over-read that reconciles site against central.
Learn more →Rater training & certification
Digital, self-led, study-specific training generated from the protocol, with signed Part 11-compliant certificates.
Learn more →Development of new eCOAs
Design and development of new outcome measures, from concept through validation, with TGA and FDA pathways planned in.
Learn more →Licence, digitisation & translation
Licence acquisition, copyright approval, faithful digital migration and translation management in one workstream.
Learn more →Digitisation support
Expert support for digitising eCOAs and digital endpoints on your platform of choice, including academic access.
Learn more →Planning a trial?
Tell us about the study — the indication, the instruments, the timeline — and we will tell you how we can help.
Talk to us about your study